Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort
利妥昔单抗时代滤泡性淋巴瘤24个月内疾病进展（POD24）：基于丹麦人群队列的发生率、临床病理危险因素和预后
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-01150-3
Enemark, Marie Hairing; Hemmingsen, Jonas Klejs; Andersen, Maja Dam; Hybel, Trine Engelbrecht; Bjørn, Mads Emil; Josefsson, Pär Lars; Pedersen, Lars Møller; Juul, Maja Bech; Pedersen, Robert Schou; Thorsgaard, Michael; Sillesen, Ida Blok; Plesner, Trine Lindhardt; Hamilton-Dutoit, Stephen Jacques; Jensen, Paw; Madsen, Charlotte; Ludvigsen, Maja
